Direct effects on human cardiomyocytes by cancer therapy with monoclonal antibodies to HER2/erbB2 are not related to apoptosis

被引:0
|
作者
Zuppinger, C
Immer, F
Sawyer, DB
Suter, TM
机构
[1] Univ Hosp, Dept Heart & Vessels, Bern, Switzerland
[2] Boston Univ, Sch Med, Cardiovasc Med Sect, Boston, MA 02118 USA
关键词
D O I
暂无
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
456
引用
收藏
页码:97 / 98
页数:2
相关论文
共 50 条
  • [1] HER2/ERBB2 immunoreactivity in human retinoblastoma
    Seigel, G. M.
    Sharma, S.
    Hackam, A. S.
    Shah, Dhaval K.
    TUMOR BIOLOGY, 2016, 37 (05) : 6135 - 6142
  • [2] ERBB2 (HER2) Testing in Breast Cancer
    Hilal, Talal
    Romond, Edward H.
    JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 2016, 315 (12): : 1280 - 1281
  • [3] Single Domain Monoclonal Antibody Specific for Her2 or ERBB2
    Omidfar, Kobra
    HYBRIDOMA, 2011, 30 (01): : 105 - 105
  • [4] Prognostic value of ErbB2/HER2 in human meningiomas
    Arnli, Magnus B.
    Winther, Theo L.
    Lydersen, Stian
    Torp, Sverre H.
    PLOS ONE, 2018, 13 (10):
  • [5] Biosimilar Therapy for ERBB2 (HER2)-Positive Breast Cancer Close Enough?
    Burstein, Harold J.
    Schrag, Deborah
    JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 2017, 317 (01): : 30 - 32
  • [6] Conditional mutation of the ErbB2 (HER2) receptor in cardiomyocytes leads to dilated cardiomyopathy
    Özcelik, C
    Erdmann, B
    Pilz, B
    Wettschureck, N
    Britsch, S
    Hübner, N
    Chien, KR
    Birchmeier, C
    Garratt, AN
    PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 2002, 99 (13) : 8880 - 8885
  • [7] Treatment options in ErbB2 (HER2)-overexpressing breast cancer
    Jackisch, Christian
    BREAST CARE, 2008, 3 : 1 - 1
  • [8] Challenges in the treatment of ErbB2 (HER2)-positiive breast cancer
    Jackisch, Christian
    EJC SUPPLEMENTS, 2008, 6 (05): : 7 - 14
  • [9] PRACTICE ADVANCES ERBB2 (HER2) Alterations in Colorectal Cancer
    Roy-Chowdhuri, Sinchita
    Davies, Kurtis D.
    Ritterhouse, Lauren L.
    Snow, Anthony N.
    JOURNAL OF MOLECULAR DIAGNOSTICS, 2022, 24 (10): : 1064 - 1066
  • [10] HER2 therapy - HER2 (ERBB2): functional diversity from structurally conserved building blocks
    Landgraf, Ralf
    BREAST CANCER RESEARCH, 2007, 9 (01)